网站地图 加入收藏 中文 English
 
首页 中心概况 组织机构 研究队伍 科学研究 人才培养 交流合作 支撑服务 人才招聘 下载专区 联系我们
当前位置:首页 - 研究队伍
曾泽贤

 

曾泽贤

 

电子邮件: zexianzeng@pku(dot)edu(dot)cn

实验室主页http://cqb.pku.edu.cn/zenglab/

 

研究方向:

 

聚焦肿瘤免疫学,有机结合数据挖掘与生物技术,研究肿瘤免疫调控机制与免疫细胞互作,揭示肿瘤免疫反应机理,旨在为临床免疫治疗成功率的提高提供新的靶向基因,为免疫调控基因的发现提供新的研究思路,为临床肿瘤用药提供新的方法。


我们正在开发多种算法和工具来整合分析高通量基因组学数据,包括 RNA-seq、WES、CRISPR筛选、单细胞测序、空间转录组学数据等。通过数据整合和算法开发,我们尝试对肿瘤发生、进展、药物反应和耐药性的特异性进行建模。当我们在数据分析中获得意想不到但有趣的结果时,我们也会设计相应的实验进行验证和探索,以期了解潜在的机制。

我们实验室也开发新的实验技术/方法对免疫微环境中细胞的调控机制进行了解,我们涉及的技术/模型/细胞有: 杀伤性CD4细胞,中性粒细胞,高级别浆液性卵巢癌类器官,CRISPR 筛选 和空间组学技术。
 

   

代表性科研论文:  

1.    Zeng Z*, Gu S*, Wong C, Li D, Lin Y, Wong C, Ouardaoui N, Zhang W, Brown M, Liu XS: A joint dimension reduction framework to model immunotherapy response for syngeneic mouse models. Science Advances (2022) 10.1126

2.    Zeng Z*, Gu S*, Yang L, Wong C, Ouardaoui N, Zhang W, Li D, Weirather J, Zhang Y, Meyer C, Rodig S, Hodi SF#, Brown M#, Liu XS#: Hippo signaling pathway regulates MHCII expression in melanoma. Cancer Immunology Research (2022) 10.1158

3.    Zeng Z*,#, Wong C*, Lin Y*, Li D, Zhang Y, Gu S, Zhang W, Kim S, Yates K, Freeman G, Brown M, Manguso R, Liu XS#: TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy response. Nucleic Acids Research (2021) 10.1093

4.    Zeng Z*, Li Y*, Li Yi*, Luo Y: Computational methods for spatially resolved transcriptomics data analysis. Genome Biology (2022) 10.02653

5.    Zeng Z*, Fu J*, Cibulskis C, Jhaveri A, Gumbs C, Das B, … & Liu XS#, Wu C#: Cross-site concordance evaluation of tumor DNA and RNA sequencing platforms for the CIMAC-CIDC network. Clinical Cancer Research. (2021).20.3251

6.    Kumar S*, Zeng Z*, Bagati A*, Tay Re*, Sanz L, Hartono SR, … & Liu XS#, Wucherpfennig K#: Carm1 inhibition enables immunotherapy of resistant tumors by dual action on tumor and T-cells. Cancer Discovery (2021). 20-1144

7.    Zhou L*, Zeng Z*, Egloff A, Zhang F, Guo F, Cambell K, Du P, … & Liu XS#, Uppaluri R#: Checkpoint blockade induced CD8+ T cell differentiation in responders in head and neck cancers. Journal for ImmunoTherapy of Cancer (2021). 10 (1), e004034

8.    Zeng Z, Vo A, Li X, Shidfar Ali, Saldana P, Xuei X, Luo Y, Khan AS, Clare SE: Somatic genetic aberrations in benign breast disease and the risk of subsequent breast cancer. npj Breast Cancer. (2020). 6(1),1-11

9.    Zeng Z, Amin A, Roy A, Pulliam N, Karavites L, Espino S, Li X, Luo Y, Khan AS: Preoperative magnetic resonance imaging and oncologic outcomes in premenopausal breast cancer patients. npj Breast Cancer. (2020). 6(1),1-8. 

10.  Zeng Z, Vo A, Mao C, Clare S, Khan S, Luo Y: Cancer classification and pathway discovering using non-negative matrix factorization. Journal of Biomedical Informatics. (2019): 103247

 

 

 

版权所有 成品直播app大全免费下载/高清免费/完整版 京ICP备15006448号-5